Glenview Trust’s Clorox CLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $491K | Buy |
5,145
+36
| +0.7% | +$3.46K | 0.01% | 376 |
|
|
2026
Q1 | $529K | Sell |
5,109
-1,153
| -18% | -$131K | 0.01% | 354 |
|
|
2025
Q4 | $631K | Buy |
6,262
+717
| +13% | +$77.8K | 0.01% | 336 |
|
|
2025
Q3 | $684K | Sell |
5,545
-18
| -0.3% | -$2.23K | 0.01% | 339 |
|
|
2025
Q2 | $668K | Sell |
5,563
-31
| -0.6% | -$4.14K | 0.01% | 333 |
|
|
2025
Q1 | $824K | Hold |
5,594
| – | – | 0.02% | 290 |
|
|
2024
Q4 | $909K | Sell |
5,594
-10
| -0.2% | -$1.64K | 0.02% | 283 |
|
|
2024
Q3 | $913K | Buy |
5,604
+760
| +16% | +$113K | 0.02% | 279 |
|
|
2024
Q2 | $661K | Sell |
4,844
-833
| -15% | -$116K | 0.01% | 303 |
|
|
2024
Q1 | $869K | Buy |
5,677
+205
| +4% | +$30.6K | 0.02% | 271 |
|
|
2023
Q4 | $780K | Sell |
5,472
-92
| -2% | -$12.3K | 0.02% | 273 |
|
|
2023
Q3 | $729K | Sell |
5,564
-32
| -0.6% | -$4.86K | 0.02% | 265 |
|
|
2023
Q2 | $890K | Hold |
5,596
| – | – | 0.02% | 245 |
|
|
2023
Q1 | $886K | Hold |
5,596
| – | – | 0.03% | 240 |
|
|
2022
Q4 | $785K | Sell |
5,596
-620
| -10% | -$88K | 0.03% | 249 |
|
|
2022
Q3 | $798K | Sell |
6,216
-220
| -3% | -$31.7K | 0.03% | 221 |
|
|
2022
Q2 | $907K | Hold |
6,436
| – | – | 0.03% | 212 |
|
|
2022
Q1 | $895K | Sell |
6,436
-226
| -3% | -$34.6K | 0.03% | 214 |
|
|
2021
Q4 | $1.16M | Sell |
6,662
-200
| -3% | -$33.3K | 0.04% | 194 |
|
|
2021
Q3 | $1.14M | Sell |
6,862
-794
| -10% | -$137K | 0.04% | 186 |
|
|
2021
Q2 | $1.38M | Sell |
7,656
-508
| -6% | -$92.7K | 0.05% | 170 |
|
|
2021
Q1 | $1.57M | Buy |
8,164
+208
| +3% | +$40K | 0.07% | 154 |
|
|
2020
Q4 | $1.61M | Sell |
7,956
-210
| -3% | -$43.5K | 0.07% | 149 |
|
|
2020
Q3 | $1.72M | Sell |
8,166
-100
| -1% | -$22.3K | 0.09% | 135 |
|
|
2020
Q2 | $1.81M | Hold |
8,266
| – | – | 0.1% | 127 |
|
|
2020
Q1 | $1.43M | Sell |
8,266
-168
| -2% | -$27.8K | 0.1% | 138 |
|
|
2019
Q4 | $1.29M | Sell |
8,434
-120
| -1% | -$17.9K | 0.07% | 162 |
|
|
2019
Q3 | $1.3M | Buy |
8,554
+300
| +4% | +$47.4K | 0.08% | 159 |
|
|
2019
Q2 | $1.26M | Hold |
8,254
| – | – | 0.08% | 161 |
|
|
2019
Q1 | $1.32M | Hold |
8,254
| – | – | 0.08% | 166 |
|
|
2018
Q4 | $1.27M | Hold |
8,254
| – | – | 0.09% | 163 |
|
|
2018
Q3 | $1.24M | Hold |
8,254
| – | – | 0.08% | 168 |
|
|
2018
Q2 | $1.12M | Sell |
8,254
-240
| -3% | -$29.6K | 0.08% | 153 |
|
|
2018
Q1 | $1.13M | Sell |
8,494
-8
| -0.1% | -$1.07K | 0.08% | 168 |
|
|
2017
Q4 | $1.26M | Hold |
8,502
| – | – | 0.09% | 161 |
|
|
2017
Q3 | $1.12M | Buy |
8,502
+828
| +11% | +$111K | 0.08% | 160 |
|
|
2017
Q2 | $1.02M | Sell |
7,674
-264
| -3% | -$35.6K | 0.08% | 163 |
|
|
2017
Q1 | $1.07M | Sell |
7,938
-225
| -3% | -$29.1K | 0.08% | 155 |
|
|
2016
Q4 | $980K | Buy |
+8,163
| New | +$963K | 0.08% | 156 |
|
|
2015
Q4 | $997K | Buy |
+7,863
| New | +$976K | 0.1% | 133 |
|
|
2014
Q4 | $974K | Buy |
+9,347
| New | +$935K | 0.1% | 117 |
|
|
2013
Q4 | $819K | Buy |
+8,833
| New | +$796K | 0.09% | 111 |
|
Other funds holding CLX
Glenview Trust's CLX Position: Q2 2026 in Review
Glenview Trust increased its Clorox (CLX) stake by 0.7% in Q2 2026, buying an estimated $3.46K and bringing the position to 5,145 shares worth $491K. The position accounts for 0.01% of the portfolio, ranked #376.
Glenview Trust first reported a position in CLX in Q4 2013 and has held it in 42 quarters since. The position peaked at $1.81M in Q2 2020. 1,041 funds tracked by Wall St. Rank hold CLX as of Q2 2026.
- Glenview Trust held 5,145 shares of Clorox worth $491K as of Q2 2026.
- Glenview Trust bought 36 Clorox shares in Q2 2026, an estimated $3.46K.
- Clorox made up 0.01% of Glenview Trust's portfolio in Q2 2026, its #376 holding.
- Glenview Trust first reported a position in Clorox in Q4 2013 and has held it in 42 quarters since.
- Glenview Trust's Clorox position peaked at $1.81M in Q2 2020.
- 1,041 funds tracked by Wall St. Rank held Clorox as of Q2 2026.
Based on Glenview Trust's 13F filing for Q2 2026, filed 11 Aug 2026.